IHE | iShares U.S. Pharmaceuticals ETFAMEXETF golden cross and death cross projections, cross tests and history

$106.72
-$0.20 (-0.19%)

iShares U.S. Pharmaceuticals ETF (IHE) is an AMEX-listed ETF that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $106.72 vs 50 $102.42 / 200 $94.97
Projection
No cross projected
Test
No active test
Last cross
Golden cross 27 Aug 2025 ยท projected 15 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $107.61 vs 50 $93.13 / 200 $72.32
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 24 Aug 2020 ยท projected 9 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $106.72 vs 50 $101.82 / 200 $101.49
Projection
No cross projected
Test
No active test
Last cross
Golden cross 5 May 2026 bar 1 ยท projected 14 bars out ยท tested 1 bar

Cross history

39
crosses on record since 2017
20 golden19 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
5 May 2026Golden4-hour14 bars out1 bar cross test
13 Apr 2026Death4-hour17 bars out3 bar cross test
27 Aug 2025Golden moderatedaily15 bars outNot tested
24 Jul 2025Golden4-hour30 bars outโ€”
17 Apr 2025Death moderatedaily29 bars out1 bar cross test

About IHE

ExchangeAMEX
InstrumentETF
Median $ volume, 60 d$17.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2017

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.